Danaher acquires AB SCIEX and Molecular Devices

Danaher Corporation (NYSE: DHR) announced today that it has completed the previously announced acquisition of AB SCIEX and Molecular Devices.  AB SCIEX is a leading designer and manufacturer of mass spectrometers, highly sensitive and sophisticated instruments used by researchers and clinicians to identify and quantify specific molecules in complex samples.  

Molecular Devices supplies high-performance bio-analytical instrumentation systems and consumables that accelerate and improve research productivity and effectiveness in life science research and drug discovery.  

Source:

Danaher Corporation

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Danaher. (2019, June 18). Danaher acquires AB SCIEX and Molecular Devices. News-Medical. Retrieved on February 05, 2023 from https://www.news-medical.net/news/20100201/Danaher-acquires-AB-SCIEX-and-Molecular-Devices.aspx.

  • MLA

    Danaher. "Danaher acquires AB SCIEX and Molecular Devices". News-Medical. 05 February 2023. <https://www.news-medical.net/news/20100201/Danaher-acquires-AB-SCIEX-and-Molecular-Devices.aspx>.

  • Chicago

    Danaher. "Danaher acquires AB SCIEX and Molecular Devices". News-Medical. https://www.news-medical.net/news/20100201/Danaher-acquires-AB-SCIEX-and-Molecular-Devices.aspx. (accessed February 05, 2023).

  • Harvard

    Danaher. 2019. Danaher acquires AB SCIEX and Molecular Devices. News-Medical, viewed 05 February 2023, https://www.news-medical.net/news/20100201/Danaher-acquires-AB-SCIEX-and-Molecular-Devices.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
Danaher offers GBP 50 million pounds for Genetix Group acquisition